StockOtters
StockOttersSupply Chain Map
BioNTech SE logo

BioNTech SE

BNTX

Financial Statements

Income Statement (Annual)

Amounts in millions

2024

12/31/2024

Revenue
2,999
Cost of Revenue
590
Gross Profit
2,409
Gross Margin
80.3%
Operating Income
-1,433
Operating Margin
-47.8%
Net Income
-725
Net Margin
-24.2%
EPS (Basic)
$-2.77
EPS (Diluted)
$-2.77
EBITDA
-400
EBITDA Margin
-13.3%

2023

12/31/2023

Revenue
4,163
Cost of Revenue
654
Gross Profit
3,509
Gross Margin
84.3%
Operating Income
753
Operating Margin
18.1%
Net Income
1,014
Net Margin
24.4%
EPS (Basic)
$3.87
EPS (Diluted)
$3.83
EBITDA
1,501
EBITDA Margin
36.1%

2022

12/31/2022

Revenue
18,869
Cost of Revenue
3,265
Gross Profit
15,604
Gross Margin
82.7%
Operating Income
13,781
Operating Margin
73.0%
Net Income
10,283
Net Margin
54.5%
EPS (Basic)
$38.08
EPS (Diluted)
$37.09
EBITDA
14,275
EBITDA Margin
75.7%

2021

12/31/2021

Revenue
20,685
Cost of Revenue
3,174
Gross Profit
17,511
Gross Margin
84.7%
Operating Income
16,659
Operating Margin
80.5%
Net Income
11,219
Net Margin
54.2%
EPS (Basic)
$43.87
EPS (Diluted)
$41.21
EBITDA
16,353
EBITDA Margin
79.1%

2020

12/31/2020

Revenue
526
Cost of Revenue
65
Gross Profit
461
Gross Margin
87.7%
Operating Income
-90
Operating Margin
-17.1%
Net Income
17
Net Margin
3.2%
EPS (Basic)
$0.06
EPS (Diluted)
$0.06
EBITDA
-115
EBITDA Margin
-21.8%